Search

Search Constraints

You searched for: Author/Creator Mehmi, Inderjit

Search Results

1. 304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma. (9th November 2020)

3. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Issue 7 (6th July 2022)

4. Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial. (16th June 2020)